Interest of Wicking for Ossicular Surgery and Myringoplasty
Launched by UNIVERSITY HOSPITAL, TOURS · Mar 1, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the use of a special tool called a "wick" that is placed in the ear after common ear surgeries, like myringoplasty (repairing the eardrum) and ossicular surgery (fixing the small bones in the middle ear). The purpose of the trial is to see how helpful this wick is in preventing complications after these surgeries. The trial is currently recruiting participants who are adults, aged 18 and older, and who understand French. To be eligible, participants must have had one of the mentioned surgeries done using specific techniques and must provide written consent.
If you choose to participate, you can expect to have your surgery as planned and then the researchers will monitor your recovery, paying special attention to any complications that might arise. It's important to note that certain individuals, such as pregnant women or those needing more complex surgical approaches, won't be able to participate in this trial. This study aims to improve surgical outcomes for ear procedures, potentially leading to better healing and fewer problems in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (age 18 = or + ), whose mother tongue is French or who understands French language
- • Ossicular surgery (fitting of a partial or total ossicular prosthesis) or myringoplasty performed endoscopically, from the speculum, from the duct or from the endaural.
- • Tympanic reconstruction by all types of grafts: cartilage, fascia, autologous fat
- • Written consent signed by the participant
- • Affiliation to a social security scheme,
- Exclusion Criteria:
- • Pregnant or breastfeeding woman, patient under legal protection, guardianship or curatorship.
- • Need for a retroauricular approach.
- • Need for annulus detachment\> 60%
- • Presence of cholesteatoma or middle ear tumor
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Blois, , France
Brest, , France
Le Mans, , France
Nantes, , France
Paris, , France
Patients applied
Trial Officials
Charles AUSSEDAT, MD
Study Director
University Hospital of TOURS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials